UNSPSC 51363501: Amobarbital/secobarbital

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN301. This VA Drug Class (CN301) classifies this compound as belonging to the group BARBITURIC ACID DERIVATIVE SEDATIVES/HYPNOTICS.

UNSPSC 51363501 Amobarbital/secobarbital is a Commodity code with minimal recent state and local procurement activity. The single recent opportunity posted under this code does not align with the code's nominal scope—Seminole County, Florida issued IFB 60459723LAS on June 30, 2026 (with a July 26, 2023 response deadline noted in the source) for Naloxone and Safe Drug Deactivation Systems, neither of which falls within the barbiturate pharmaceutical category the code describes. This mismatch suggests either mis-tagging by the issuing body or incidental use of the code for unrelated pharmaceutical procurement.

The Seminole County opportunity sought 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with vendors responsible for all shipping and delivery costs. The contract carried a two-year initial term with a one-year renewal option and required E-Verify compliance, drug-free workplace certification, and standard insurance coverage including workers' compensation, commercial general liability, and professional liability. The procurement appears potentially funded through FEMA, subjecting vendors to additional federal compliance requirements. Without additional recent opportunities under this code, current market visibility is limited, and firms should verify actual buyer intent before investing significantly in pursuit under this Commodity classification.